CMTS0929 therapy for inflammatory bowel disease
Part of Digestive system clinical trials.
This trial tests a new treatment called CMTS0929 for people with inflammatory bowel disease (IBD). It aims to see if this treatment is safe and helps manage IBD symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of inflammatory bowel disease (IBD) confirmed by your doctor.
- You must be between 18 and 75 years old.
- You must not have taken antibiotics, prebiotics, or probiotics in the past month.
- You must not be pregnant or planning to become pregnant during the trial.
- You must not have serious health issues like heart disease, liver or kidney problems, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests new therapies for people with moderate to severe Crohn's disease or ulcerative colitis. It may help if your standard treatments aren't working well enough.
This trial tests an experimental treatment called CMTS0929 for people with a C. difficile infection that is causing diarrhea. The treatment is given through a tube placed through the nostril or mouth into the intestine, and the study will see if it is safe and helpful.
This trial tests a treatment called washed microbiota transplantation (WMT), which aims to restore healthy gut bacteria to help reduce chronic diarrhea. WMT involves processing donated stool and delivering it to the patient's gut, and it may offer a new option for people who haven't found relief from other treatments.
This trial tests a new medicine (TQH3906) for people with moderate to severe ulcerative colitis or Crohn's disease that hasn't improved with other treatments. The goal is to see if it can help control inflammation in the gut.
This trial tests a new treatment using modified immune cells (CAR-T cells) to reduce inflammation in people with moderate to severe inflammatory bowel disease (IBD) that hasn't improved with other advanced treatments.
This study tests if a standardized fecal transplant is safe and helpful for adults with moderately to severely active Crohn's disease who are already on maintenance therapy. The goal is to see if this treatment can reduce inflammation in the digestive tract.
Hear when a new Inflammatory Bowel Disease (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.